A 32-year-old male patient with a history of treatment resistant paranoid schizophrenia developed neuroleptic malignant syndrome (NMS) during changeover of his antipsychotic medication from zuclopenthixol depot to clozapine. This case highlights the difficulties of cross-tapering two antipsychotics-that is, converting from a typical depot medication to an oral atypical antipsychotic.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3027363 | PMC |
| http://dx.doi.org/10.1136/bcr.07.2008.0429 | DOI Listing |
Publication Analysis
Top Keywords
neuroleptic malignant
8
malignant syndrome
8
case report
4
report neuroleptic
4
syndrome 32-year-old
4
32-year-old male
4
male patient
4
patient history
4
history treatment
4
treatment resistant
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!